The role of PPARs in atherosclerosis
- 1 September 2002
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (9) , 422-430
- https://doi.org/10.1016/s1471-4914(02)02385-7
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Peroxisome Proliferator–Activated Receptor-γ Ligands Inhibit Nuclear but Not Cytosolic Extracellular Signal–Regulated Kinase/Mitogen–Activated Protein Kinase–Regulated Steps in Vascular Smooth Muscle Cell MigrationJournal of Cardiovascular Pharmacology, 2001
- PPARγ Ligands Inhibit TNF-α-Induced LOX-1 Expression in Cultured Endothelial CellsBiochemical and Biophysical Research Communications, 2001
- Cloning of the Human Cholesteryl Ester Hydrolase Promoter: Identification of Functional Peroxisomal Proliferator-Activated Receptor Responsive ElementsBiochemical and Biophysical Research Communications, 2001
- Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular EndotheliumBiochemical and Biophysical Research Communications, 2001
- Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator–activated receptor γJournal of Clinical Investigation, 2000
- Activation of PPARα or γ Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 CellsBiochemical and Biophysical Research Communications, 2000
- Lipoprotein lipase, a key role in atherosclerosis?FEBS Letters, 1999
- PPARγ Agonists Enhance Human Vascular Endothelial Adhesiveness by Increasing ICAM-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Another Potential Use of Troglitazone in Noninsulin-Dependent Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1998